Document is current
Any future updates will be listed below
-
Authors
Zimmermann, Pauline https://orcid.org/0009-0006-6263-3614
Kaar, Martin
Bokeloh, Theresa
Moll, Lotta
Labinski, Franziska
Eippert, Falk https://orcid.org/0000-0002-3986-1719
Blüher, Matthias
Stumvoll, Michael https://orcid.org/0000-0001-6225-8240
Heinitz, Sascha https://orcid.org/0000-0002-5010-6183
Schlögl, Haiko https://orcid.org/0000-0002-3967-5318
-
Funding
Funding for this research was provided by:
Besins Healthcare
Deutsche Forschungsgemeinschaft (EXC-3105/1 – 533765739)
- License Information
-
More Information
Article History
Received: 5 February 2025
Accepted: 27 January 2026
First Online: 7 February 2026
Competing interests
: H.S. received financial support for this study from Besins Healthcare. The funder had no role in the study design, data collection, data analysis, interpretation of results, or the writing of the manuscript. M.B. received honoraria as a consultant and speaker from Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Lilly, Novo Nordisk, Novartis, and Sanofi. All other authors have no competing interests.
